Technical Comparison
PharmaCyte Biotech, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between PMCB and NVDA.
Primary Asset
PMC
PharmaCyte Biotech, Inc. - Common Stock
Market Rank #1003826Live Price$0.55
Market Capitalization$5.9M
24h Change-3.41%
Circulating Supply11M PMCB
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$225.30
Market Capitalization$5.5T
24h Change+0.54%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | PMCB Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1003826 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $0.55 | $225.30 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $5.9M | $5.5T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is PharmaCyte Biotech, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
PharmaCyte Biotech, Inc. - Common Stock has a market cap of $5.9M, while NVIDIA Corporation - Common Stock sits at $5.5T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between PharmaCyte Biotech, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 PMCB is worth 0.002441 NVDA.